ResearcherHarvard UniversityNo recent work listed
Vladimír Janout
Matched on ORCID iD 0000-0003-1594-3901; OpenAlex author ID A5057649971. Sources: OpenAlex.
Their work
- Papers
- 16 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 64
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper
Papers 16
- Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
- Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. Co-author DOI 10.1016/j.ebiom.2019.09.042↗
- A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy126↗
- Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
- High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Co-author DOI 10.1093/annonc/mdx004↗
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw266↗
- Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
- Evaluation of Dietary Habits in the Study of Pancreatic Cancer. Co-author DOI 10.14735/amko2016196↗
- KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control. Co-author DOI 10.18632/oncotarget.12386↗
- Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
- Physical activity and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1007/s10552-014-0370-x↗
- Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
- Is physical activity a protective factor against pancreatic cancer? Last author DOI 10.4149/bll_2014_091↗
- [Pancreatic cancer and lifestyle factors]. Co-author DOI 10.14735/amko2013257↗
- Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1002/ijc.25959↗
Closest collaborators
The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ghislaine Scélo · 8 shared papers, 2011–2020 · strength 0.40
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042↗
- Paper A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djy126↗
- Paper Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw266↗
- Paul Brennan · 6 shared papers, 2011–2020 · strength 0.32
- Paper Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments … DOI 10.1016/j.ebiom.2019.09.042↗
- Paper A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djy126↗
- Paper High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. DOI 10.1093/annonc/mdx004↗
- Arnošt Martínek · 5 shared papers, 2011–2016 · strength 0.20
- Samir Hanash · 3 shared papers, 2017–2019 · strength 0.17
- Paper A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djy126↗
- Paper Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw266↗
- Paper High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. DOI 10.1093/annonc/mdx004↗
- Anirban Maitra · 3 shared papers, 2017–2019 · strength 0.17
- Paper A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djy126↗
- Paper Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw266↗
- Paper High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. DOI 10.1093/annonc/mdx004↗
- Kateřina Azeem · 3 shared papers, 2013–2016 · strength 0.14
- Helena Kollárová · 3 shared papers, 2013–2016 · strength 0.14
- Florence Le Calvez‐Kelm · 2 shared papers, 2016–2020 · strength 0.14
- Michela Capello · 2 shared papers, 2017–2019 · strength 0.12
- Leonidas E. Bantis · 2 shared papers, 2017–2019 · strength 0.12
- Randall E. Brand · 2 shared papers, 2017–2019 · strength 0.12
- Matthew H. G. Katz · 2 shared papers, 2017 · strength 0.10
- Maria I. Zvereva · 1 shared paper, 2020 · strength 0.09
- Dali Li · 2 shared papers, 2014–2017 · strength 0.08
- Michele Yip-Schneider · 1 shared paper, 2019 · strength 0.07
- Jody V. Vykoukal · 1 shared paper, 2019 · strength 0.07
- Johannes Francois Fahrmann · 1 shared paper, 2019 · strength 0.07
- Jianjun Zhang · 1 shared paper, 2019 · strength 0.07
- Ziding Feng · 1 shared paper, 2019 · strength 0.07
- Christian Max Schmidt · 1 shared paper, 2019 · strength 0.07
- Sara H. Olson · 2 shared papers, 2014–2016 · strength 0.07
- Paper Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancrea… DOI 10.1097/mpa.0000000000000635↗
- Paper Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Ca… DOI 10.1093/annonc/mdu276↗
- H. Bas Bueno-de-Mesquita · 2 shared papers, 2014–2016 · strength 0.07
- Paper Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancrea… DOI 10.1097/mpa.0000000000000635↗
- Paper Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Ca… DOI 10.1093/annonc/mdu276↗
- Eric J. Duell · 2 shared papers, 2014–2016 · strength 0.07
- Paper Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancrea… DOI 10.1097/mpa.0000000000000635↗
- Paper Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Ca… DOI 10.1093/annonc/mdu276↗
- Robert C. Kurtz · 2 shared papers, 2014–2016 · strength 0.07
- Paper Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancrea… DOI 10.1097/mpa.0000000000000635↗
- Paper Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Ca… DOI 10.1093/annonc/mdu276↗
- Steve Gallinger · 2 shared papers, 2014–2016 · strength 0.07
- Paper Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancrea… DOI 10.1097/mpa.0000000000000635↗
- Paper Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Ca… DOI 10.1093/annonc/mdu276↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.